An Overview of Immune Checkpoint Blockade

April 16, 2014
Jedd D. Wolchok, MD, PhD

Special Reports, Melanoma (Issue 2), Volume 2, Issue 1

Jedd D. Wolchok, MD, PhD, chief, Melanoma and Immunotherapeutics Service, Lloyd J. Old Chair for Clinical Investigation, Memorial Sloan Kettering Cancer Center, explains immune checkpoint blockade.

Jedd D. Wolchok, MD, PhD, chief, Melanoma and Immunotherapeutics Service, Lloyd J. Old Chair for Clinical Investigation, Memorial Sloan Kettering Cancer Center, explains immune checkpoint blockade.

Read more about immunotherapies and combination strategies for the treatment of melanoma > >